Diagnosing amyloidosis, currently available therapies & the importance of cardio-oncology

While there have been advances in the treatment and management of amyloidosis in recent years, diagnosis remains a challenge due to the highly varied presentation of this disease. As clinicians and researchers work to improve outcomes for patients, there is increasing importance being placed on the role of the multidisciplinary team in treating these patients. In this podcast, you will hear from Morie Gertz, MD, MACP, Mayo Clinic, Rochester, MN, Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM, University College London Hospitals NHS Foundation Trust, London, UK, and Daniel Lenihan, MD, FACC, Saint Francis Health System, Cape Girardeau, MO, who discuss the significant role of cardio-oncology in amyloidosis, currently available therapies, diagnostic approaches being explored, and more.